fluorobenzenes has been researched along with Embolism, Cholesterol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burtseva, EA; Goloviuk, AL; Ivanov, LO; Kuntsevich, GI; PokrovskiÄ, AV; Suntsov, DS; Zotikov, AE | 1 |
Asai, O; Iwano, M; Matsui, M; Nakatani, K; Saito, Y; Sakan, H | 1 |
2 other study(ies) available for fluorobenzenes and Embolism, Cholesterol
Article | Year |
---|---|
[Rosuvastatin in prevention of cardiac complications following surgical treatment of patients with vascular pathology].
Topics: Adult; Aged; Aorta, Abdominal; Atherosclerosis; Brachiocephalic Trunk; Dose-Response Relationship, Drug; Embolism, Cholesterol; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Postoperative Complications; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Time Factors; Treatment Outcome; Vascular Surgical Procedures | 2009 |
[Case of purpura nephritis accompanied by idiopathic cholesterol embolism].
Topics: Aged; Embolism, Cholesterol; Fluorobenzenes; Humans; IgA Vasculitis; Kidney Glomerulus; Kidney Tubules; Male; Nephritis; Prednisolone; Proteinuria; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2012 |